2022 Q4 Form 10-Q Financial Statement

#000149315223024801 Filed on July 18, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2021 Q4
Revenue $3.954M $5.401M
YoY Change -26.78% 106.13%
Cost Of Revenue $3.153M $3.316M
YoY Change -4.9% 109.85%
Gross Profit $801.4K $2.085M
YoY Change -61.56% 100.47%
Gross Profit Margin 20.27% 38.61%
Selling, General & Admin $6.167M $37.09M
YoY Change -83.37% 2915.1%
% of Gross Profit 769.52% 1778.75%
Research & Development $1.058M $103.3K
YoY Change 924.16% 416.6%
% of Gross Profit 132.04% 4.96%
Depreciation & Amortization $487.2K $90.79K
YoY Change 436.67%
% of Gross Profit 60.8% 4.35%
Operating Expenses $7.225M $37.19M
YoY Change -80.57% 2899.11%
Operating Profit -$6.424M -$35.10M
YoY Change -81.7% 17452.04%
Interest Expense -$1.009M $4.575M
YoY Change -122.06% -2179.75%
% of Operating Profit
Other Income/Expense, Net -$4.600M -$2.629M
YoY Change 74.96% 5158.14%
Pretax Income -$11.02M -$38.83M
YoY Change -71.61% 1440.69%
Income Tax
% Of Pretax Income
Net Earnings -$11.02M -$38.83M
YoY Change -71.61% 1440.69%
Net Earnings / Revenue -278.77% -718.92%
Basic Earnings Per Share -$1.00 -$9.45
Diluted Earnings Per Share -$1.00 -$945.1K
COMMON SHARES
Basic Shares Outstanding 11.02M shares 4.108M shares
Diluted Shares Outstanding 11.02M shares 4.108M shares

Balance Sheet

Concept 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $465.0K $1.748M
YoY Change -73.39% 168.87%
Cash & Equivalents $465.0K $1.748M
Short-Term Investments
Other Short-Term Assets $1.971M $586.9K
YoY Change 235.81% 117.36%
Inventory $4.687M $8.578M
Prepaid Expenses
Receivables $741.9K $846.5K
Other Receivables $0.00 $1.435M
Total Short-Term Assets $8.048M $13.19M
YoY Change -39.0% 313.63%
LONG-TERM ASSETS
Property, Plant & Equipment $130.8K
YoY Change
Goodwill $32.64M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.418M
YoY Change
Total Long-Term Assets $60.99M $3.531M
YoY Change 1627.33%
TOTAL ASSETS
Total Short-Term Assets $8.048M $13.19M
Total Long-Term Assets $60.99M $3.531M
Total Assets $69.04M $16.73M
YoY Change 312.77% 424.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.712M $5.306M
YoY Change 7.64% 305.07%
Accrued Expenses $7.551M $2.033M
YoY Change 271.47% 341.9%
Deferred Revenue $2.241M
YoY Change
Short-Term Debt $803.7K $0.00
YoY Change -100.0%
Long-Term Debt Due $2.628M
YoY Change
Total Short-Term Liabilities $28.69M $24.91M
YoY Change 15.19% 171.63%
LONG-TERM LIABILITIES
Long-Term Debt $2.000M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.207M
YoY Change
Total Long-Term Liabilities $3.207M $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.69M $24.91M
Total Long-Term Liabilities $3.207M $0.00
Total Liabilities $31.90M $24.91M
YoY Change 28.06% 159.73%
SHAREHOLDERS EQUITY
Retained Earnings -$95.89M
YoY Change
Common Stock $132.8M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $37.14M -$8.183M
YoY Change
Total Liabilities & Shareholders Equity $69.04M $16.73M
YoY Change 312.77% 424.31%

Cashflow Statement

Concept 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income -$11.02M -$38.83M
YoY Change -71.61% 1440.69%
Depreciation, Depletion And Amortization $487.2K $90.79K
YoY Change 436.67%
Cash From Operating Activities -$3.191M -$5.895M
YoY Change -45.86% -11889.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$1.100M
YoY Change -100.0%
Cash From Investing Activities $0.00 -$1.100M
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.939M 7.709M
YoY Change -74.85% 1441.88%
NET CHANGE
Cash From Operating Activities -3.191M -5.895M
Cash From Investing Activities 0.000 -1.100M
Cash From Financing Activities 1.939M 7.709M
Net Change In Cash -1.252M 714.7K
YoY Change -275.23% 29.94%
FREE CASH FLOW
Cash From Operating Activities -$3.191M -$5.895M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001674440
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
CY2022Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CNXA Loss On Issuance Of Convertible Notes
LossOnIssuanceOfConvertibleNotes
usd
CNXA Derivative Expense
DerivativeExpense
usd
CY2021Q4 CNXA Derivative Expense
DerivativeExpense
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2022Q4 CNXA Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
usd
CY2022Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
usd
CNXA Gain On Change In Fair Value Of Contingent Consideration
GainOnChangeInFairValueOfContingentConsideration
usd
CNXA Gain On Change In Fair Value Of Contingent Consideration
GainOnChangeInFairValueOfContingentConsideration
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CNXA Derivative Expense
DerivativeExpense
usd
CNXA Noncash Transaction Costs
NoncashTransactionCosts
usd
CNXA Noncash Transaction Costs
NoncashTransactionCosts
usd
CNXA Loss On Issuance Of Convertible Notes
LossOnIssuanceOfConvertibleNotes
usd
CNXA Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
usd
CNXA Increase Decrease In Right Of Use Assets Operating Leases
IncreaseDecreaseInRightOfUseAssetsOperatingLeases
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Stock Issued1
StockIssued1
usd
CNXA Shares Issued For Contingent Consideration
SharesIssuedForContingentConsideration
usd
CNXA Elimination Of Related Party Derivative Liabilities
EliminationOfRelatedPartyDerivativeLiabilities
usd
CNXA Derivative Liabilities Recorded As Debt Discounts Of Convertible Notes
DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes
usd
CNXA Derivative Liability Recorded For Shares And Warrants Issued In Private Placement
DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement
usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-10-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
01-41423
dei Entity Registrant Name
EntityRegistrantName
CONNEXA SPORTS TECHNOLOGIES INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1789640
dei Entity Address Address Line1
EntityAddressAddressLine1
2709 NORTH ROLLING ROAD
dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 138
dei Entity Address City Or Town
EntityAddressCityOrTown
WINDSOR MILL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21244
dei City Area Code
CityAreaCode
(443)
dei Local Phone Number
LocalPhoneNumber
407-7564
dei Security12b Title
Security12bTitle
common stock, par value $0.001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19394429 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465017 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1424360 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
145798 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
156724 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
741921 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1322370 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4686661 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
8185144 usd
CY2022Q4 CNXA Prepaid Inventory
PrepaidInventory
810325 usd
CY2022Q2 CNXA Prepaid Inventory
PrepaidInventory
499353 usd
CY2022Q4 CNXA Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
103228 usd
CY2022Q2 CNXA Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
239689 usd
CY2022Q4 us-gaap Commodity Contract Asset Current
CommodityContractAssetCurrent
184070 usd
CY2022Q2 us-gaap Commodity Contract Asset Current
CommodityContractAssetCurrent
235526 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
911451 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
762930 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
8048471 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
12826096 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
130840 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
174217 usd
CY2022Q4 us-gaap Commodity Contract Asset Noncurrent
CommodityContractAssetNoncurrent
193019 usd
CY2022Q2 us-gaap Commodity Contract Asset Noncurrent
CommodityContractAssetNoncurrent
209363 usd
CY2022Q4 CNXA Finished Products Used In Operations Net
FinishedProductsUsedInOperationsNet
4417986 usd
CY2022Q2 CNXA Finished Products Used In Operations Net
FinishedProductsUsedInOperationsNet
4693575 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23605308 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24316502 usd
CY2022Q4 us-gaap Goodwill
Goodwill
32643193 usd
CY2022Q2 us-gaap Goodwill
Goodwill
32643193 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
60990346 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
62036850 usd
CY2022Q4 us-gaap Assets
Assets
69038817 usd
CY2022Q2 us-gaap Assets
Assets
74862946 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5711875 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6465373 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7550909 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5602011 usd
CY2022Q2 us-gaap Purchase Obligation
PurchaseObligation
500000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2241283 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2656706 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
78016 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
237204 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
23342 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
708677 usd
CY2022Q4 CNXA Interest Payable To Related Parties Current
InterestPayableToRelatedPartiesCurrent
903938 usd
CY2022Q2 CNXA Interest Payable To Related Parties Current
InterestPayableToRelatedPartiesCurrent
908756 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
10327778 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
10936469 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5443779 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
418455 usd
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1334000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22971 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
156862 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
28690958 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
38980522 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
2000000 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
2000000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1206844 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1370492 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3206844 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3370492 usd
CY2022Q4 us-gaap Liabilities
Liabilities
31897802 usd
CY2022Q2 us-gaap Liabilities
Liabilities
42351014 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13230416 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13230416 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4194836 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4194836 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
13231 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
4195 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
132788009 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
113049700 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95886923 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80596925 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
226698 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
54962 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
37141015 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
32511932 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69038817 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74862946 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8900828 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7938115 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3954379 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5400542 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6707375 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5067956 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3152984 usd
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3315605 usd
us-gaap Gross Profit
GrossProfit
2193453 usd
us-gaap Gross Profit
GrossProfit
2870159 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
801395 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
2084937 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1919855 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1594906 usd
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
721346 usd
CY2021Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
887809 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9789018 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38592687 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5445521 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36197888 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1892931 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
277366 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1058157 usd
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
103318 usd
us-gaap Operating Expenses
OperatingExpenses
13601804 usd
us-gaap Operating Expenses
OperatingExpenses
40464959 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
7225024 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
37189015 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11408351 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-37594800 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6423629 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-35104078 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2872222 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2650285 usd
CY2021Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2629069 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7096730 usd
CY2021Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1978295 usd
CNXA Loss On Issuance Of Convertible Notes
LossOnIssuanceOfConvertibleNotes
-3689369 usd
CY2021Q4 CNXA Loss On Issuance Of Convertible Notes
LossOnIssuanceOfConvertibleNotes
-3689369 usd
CNXA Gain On Change In Fair Value Of Derivatives Liability
GainOnChangeInFairValueOfDerivativesLiability
6787597 usd
CNXA Gain On Change In Fair Value Of Derivatives Liability
GainOnChangeInFairValueOfDerivativesLiability
9130913 usd
CY2022Q4 CNXA Gain On Change In Fair Value Of Derivatives Liability
GainOnChangeInFairValueOfDerivativesLiability
3100102 usd
CY2021Q4 CNXA Gain On Change In Fair Value Of Derivatives Liability
GainOnChangeInFairValueOfDerivativesLiability
4803569 usd
CNXA Derivative Expense
DerivativeExpense
7280405 usd
CY2022Q4 CNXA Derivative Expense
DerivativeExpense
7280405 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3881647 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4665869 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4599938 usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3721279 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15289998 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42260669 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11023567 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38825357 usd
us-gaap Net Income Loss
NetIncomeLoss
-15289998 usd
us-gaap Net Income Loss
NetIncomeLoss
-42260669 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-11023567 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-38825357 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
171736 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7824 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
113597 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
20852 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15118262 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42252845 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10909970 usd
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38804505 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-12.04
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-12.04
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-9.45
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9022466 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3510458 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11018824 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4108073 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9022466 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3510458 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11018824 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4108073 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-18450744 usd
CY2021Q3 CNXA Stock Issued During Period Value Conversionof Notes Payable Related Parties
StockIssuedDuringPeriodValueConversionofNotesPayableRelatedParties
6220003 usd
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3550000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
618554 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
187803 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13028 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3435312 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-11322724 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-11322724 usd
CY2021Q4 CNXA Stock Issued During Period Value Conversionof Lliability Shares Issuable
StockIssuedDuringPeriodValueConversionofLliabilitySharesIssuable
6911 usd
CY2021Q4 CNXA Stock Issued During Period Value Conversion Of Warrants
StockIssuedDuringPeriodValueConversionOfWarrants
2750 usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
799174 usd
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
32381309 usd
CY2021Q4 CNXA Adjustments To Additional Paid In Capital Elimination Of Related Party Derivative Liabilities
AdjustmentsToAdditionalPaidInCapitalEliminationOfRelatedPartyDerivativeLiabilities
8754538 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
20852 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-38825357 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8182547 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8182547 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
32511932 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
14046300 usd
CY2022Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
915545 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
35250 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4195000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
277625 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
58139 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4266431 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
47773360 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
47773360 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
277625 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
113597 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
113597 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-11023567 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
37141015 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
37141015 usd
us-gaap Net Income Loss
NetIncomeLoss
-15289998 usd
us-gaap Net Income Loss
NetIncomeLoss
-42260669 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
754571 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
131958 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
6787597 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
9130913 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
35250 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1417728 usd
us-gaap Share Based Compensation
ShareBasedCompensation
555250 usd
us-gaap Share Based Compensation
ShareBasedCompensation
32569112 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7096730 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2872222 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2650285 usd
CNXA Derivative Expense
DerivativeExpense
7280405 usd
CNXA Loss On Issuance Of Convertible Notes
LossOnIssuanceOfConvertibleNotes
-3689369 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-576454 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
84262 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3765057 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4886227 usd
CNXA Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
-311972 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-67800 usd
CNXA Increase Decrease In Right Of Use Assets Operating Leases
IncreaseDecreaseInRightOfUseAssetsOperatingLeases
-136461 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
127577 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
422119 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
490004 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
3183575 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-520852 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-28289 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-159188 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
10974 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
160963 usd
CNXA Increase Decrease In Interest Payable Related Party
IncreaseDecreaseInInterestPayableRelatedParty
-4818 usd
CNXA Increase Decrease In Interest Payable Related Party
IncreaseDecreaseInInterestPayableRelatedParty
74289 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
8793407 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
36261236 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6496591 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5999433 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
1400000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1400000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9194882 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
790580 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
11000000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
14133 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3835676 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2677979 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4397098 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2099369 usd
CY2022Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2559848 usd
CY2022Q4 CNXA Capitalized Duty And Freight
CapitalizedDutyAndFreight
209313 usd
CY2022Q2 CNXA Capitalized Duty And Freight
CapitalizedDutyAndFreight
1328198 usd
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
300000 usd
CY2022Q2 us-gaap Inventory Adjustments
InventoryAdjustments
100000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5345073 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8209420 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
181249 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8878 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-970269 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
818865 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1581084 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
928796 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
610815 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1747661 usd
us-gaap Interest Paid Net
InterestPaidNet
482687 usd
us-gaap Interest Paid Net
InterestPaidNet
111105 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3896 usd
us-gaap Stock Issued1
StockIssued1
3550000 usd
CNXA Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
14046300 usd
CNXA Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
6220003 usd
CNXA Shares Issued For Contingent Consideration
SharesIssuedForContingentConsideration
915545 usd
CNXA Elimination Of Related Party Derivative Liabilities
EliminationOfRelatedPartyDerivativeLiabilities
8754538 usd
CNXA Derivative Liabilities Recorded As Debt Discounts Of Convertible Notes
DerivativeLiabilitiesRecordedAsDebtDiscountsOfConvertibleNotes
10199749 usd
CNXA Derivative Liability Recorded For Shares And Warrants Issued In Private Placement
DerivativeLiabilityRecordedForSharesAndWarrantsIssuedInPrivatePlacement
4999882 usd
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3486599 usd
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10 reverse stock split
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95886923 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zvVWL6UaVqj7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zWAEcjH5H3s4">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziQp2PTDvFUf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_869_zpQLnipAsFp2">Financial Statement Reclassification</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with the current year presentation and had no effect on the Company’s balance sheet, net loss, shareholders’ deficit or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
175000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
175000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4686661 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
8185144 usd
CY2022Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zQkuAxhjAct3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_z6KnIX5M9JW1">Concentration of Credit Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations or financial condition. See Note 4 for further details on the Company’s concentration of credit risk as well as other risks and uncertainties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
10936469 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
6787597 usd
CY2022Q3 CNXA Derivative Expense
DerivativeExpense
7280405 usd
CY2022Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2022 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1056599 usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2430000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
32643193 usd
CY2022Q4 us-gaap Goodwill
Goodwill
32643193 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
712980 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
131958 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1572905 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1824808 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2569690 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3330667 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3122430 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
11184808 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23605308 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
3222429 usd
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2011149 usd
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1416606 usd
CY2022Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1114753 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1300000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1706560 usd
CY2022Q4 CNXA Goods Received Not Invoiced
GoodsReceivedNotInvoiced
732910 usd
CY2022Q2 CNXA Goods Received Not Invoiced
GoodsReceivedNotInvoiced
293413 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
878964 usd
CY2022Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
476136 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7550909 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5602011 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
12026668 usd
CY2022Q4 CNXA Remaining Derivative Liabilities
RemainingDerivativeLiabilities
1862450 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
800251 usd
CY2021Q4 CNXA Convertible Debt Discount
ConvertibleDebtDiscount
14689369 usd
CY2021Q4 CNXA Loss On Issuance Of Convertible Notes
LossOnIssuanceOfConvertibleNotes
-3689369 usd
CY2021Q4 CNXA Securities Outstanding Rate Convertible Notes Descripition
SecuritiesOutstandingRateConvertibleNotesDescripition
On December 31, 2021, the Company entered into an Omnibus Amendment Agreement (the “Omnibus Agreement”) with certain Purchasers who are collectively holders of 67% or more of the Securities outstanding related to the August 6, 2021 Convertible Notes, amending each of (i) the Purchase Agreement and (ii) the Registration Rights Agreement. Simultaneously with the execution of the Omnibus Agreement, the Company issued to each Purchaser a Replacement Note (as defined below) in replacement of the Convertible Note held prior to December 31, 2021 by such Purchaser (each, an “Existing Note”).
CY2022Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4389469 shares
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
13200000 usd
CY2022Q2 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
846301 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
0 usd
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
13200000 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1501914 usd
CY2021Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1250004 usd
CY2022Q1 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
4000000 usd
CY2022Q1 CNXA Number Of Consigned Goods
NumberOfConsignedGoods
13000 integer
CNXA Payments Of Related Party Debt
PaymentsOfRelatedPartyDebt
4000000 usd
CY2022Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2022-07-01
CY2022Q3 CNXA Payments Of Related Party Debt
PaymentsOfRelatedPartyDebt
500000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13230416 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13230416 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4194836 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4194836 shares
CY2022Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6063145 shares
CY2022Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4389469 shares
CY2022Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
1923920 shares
us-gaap Payments For Rent
PaymentsForRent
2100 usd
us-gaap Payments For Rent
PaymentsForRent
6550 usd
CY2022Q3 CNXA Fair Value Of Common Stock
FairValueOfCommonStock
1334000 usd
CY2022 CNXA Fair Value Of Common Stock
FairValueOfCommonStock
1334000 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
598396 shares
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
418455 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 integer
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8900828 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7938115 usd
us-gaap Profit Loss
ProfitLoss
-15284964 usd
us-gaap Profit Loss
ProfitLoss
-42260669 usd

Files In Submission

Name View Source Status
0001493152-23-024801-index-headers.html Edgar Link pending
0001493152-23-024801-index.html Edgar Link pending
0001493152-23-024801.txt Edgar Link pending
0001493152-23-024801-xbrl.zip Edgar Link pending
cnxa-20221031.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
cnxa-20221031_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cnxa-20221031_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cnxa-20221031_def.xml Edgar Link unprocessable
cnxa-20221031_cal.xml Edgar Link unprocessable